1-3 of 3
Athanasios Anagnostopoulos, MD, PhD
Close
Sort by
Journal Articles

The Combination of Bortezomib, Melphalan, Dexamethasone and Intermittent Thalidomide (VMDT) Is an Effective Treatment for Relapsed/Refractory Myeloma: Results of a Phase II Clinical Trial.

Evangelos Terpos, MD, PhD, Athanasios Anagnostopoulos, MD, PhD, Efstathios Kastritis, MD, Athanasios Zomas, MD, Christos Poziopoulos, MD, Nikolaos Anagnostopoulos, MD, PhD, Konstantinos Tsionos, MD, Meletios A. Dimopoulos, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 363.
https://doi.org/10.1182/blood.V106.11.363.363
Published: 2005
Journal Articles

Macrophage Inflammatory Protein-1 alpha (MIP-1α) Is Increased in Patients with Waldenstrom’s Macroglobulinemia and Correlates with the Severity of Disease.

Evangelos Terpos, MD, PhD, Athanasios Anagnostopoulos, MD, PhD, Efstathios Kastritis, MD, Aristotelis Bamias, MD, PhD, Konstantinos Tsionos, MD, Meletios A. Dimopoulos, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2498.
https://doi.org/10.1182/blood.V106.11.2498.2498
Published: 2005
Journal Articles

Angiogenic Cytokines Are Increased in the Serum of Patients with Waldenstrom’s Macroglobulinemia: Correlations with Clinical Data.

Athanasios Anagnostopoulos, MD, PhD, Evangelos Terpos, MD, PhD, Efstathios Kastritis, MD, Aristotelis Bamias, MD, PhD, Konstantinos Tsionos, MD, Meletios A. Dimopoulos, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2504.
https://doi.org/10.1182/blood.V106.11.2504.2504
Published: 2005